Zobrazeno 1 - 10
of 28
pro vyhledávání: '"R H Böger"'
Autor:
R. H. Böger
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 129:820-824
Publikováno v:
Scopus-Elsevier
Background: Our aim was to compare the effects of exercise on systemic nitric oxide formation, assessed from the urinary excretion rates of nitrate and of cyclic GMP, in endurance-trained and untrained men.Methods: Ten endurance-trained and six untra
Autor:
R H, Böger, H G, Endres, E, Schwedhelm, H, Darius, D, Atzler, N, Lüneburg, B, von Stritzky, R, Maas, U, Thiem, R A, Benndorf, C, Diehm
Publikováno v:
Journal of internal medicine. 269(3)
Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide (NO) synthesis causing endothelial dysfunction, an early sign of atherogenesis. Symmetric dimethylarginine (SDMA) does not inhibit NO synthases. Peripheral arterial disease
Autor:
D. Rubin, E. Schwedhelm, U. Helwig, D. Bell, R. H. Böger, K. Fielitz, J. Schrezenmeir, P. Winkler, M. Pfeuffer, C. Laue
Publikováno v:
Aktuelle Ernährungsmedizin. 32
Autor:
R H, Böger
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 129(15)
Publikováno v:
Zeitschrift fur Kardiologie. 92(6)
Drug therapy of coronary heart disease (CHD) is a life-long treatment. With every change from in-patient to out-patient care and back, changes in medication may occur. If a drug is chosen which provides no proven long-term benefit in terms of reduced
Autor:
R H, Böger
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 127(34-35)
Autor:
R H, Böger
Publikováno v:
Der Internist. 43(4)
Autor:
H A, Walker, E, McGing, I, Fisher, R H, Böger, S M, Bode-Böger, G, Jackson, J M, Ritter, P J, Chowienczyk
Publikováno v:
Journal of the American College of Cardiology. 38(2)
This study was designed to determine the effect of two weeks' treatment with L-arginine on the ratio of plasma L-arginine to asymmetric dimethylarginine (ADMA), oxidative stress, endothelium-dependent vasodilatation to acetylcholine, exercise perform
Autor:
K, Sydow, R H, Böger
Publikováno v:
Zeitschrift fur Kardiologie. 90(1)
Elevated homocyst(e)ine plasma concentrations are an independent risk factor for cardiovascular disease. Hyperhomocyst(e)inaemia is common in patients with peripheral arterial occlusive disease, coronary heart disease, cerebrovascular disease, caroti